Uncategorized
Ranibizumab improves diabetic retinopathy severity score
SAN FRANCISCO — Treatment with ranibizumab led to improvement in diabetic retinopathy severity scores in a subanalysis of RISE and RIDE data, a speaker here said.“My objective in this subanalysis of RIDE and RISE was to evaluate the effect of ranibizumab in eyes at particularly high risk of progression to [proliferative diabetic retinopathy] in the near-term future, focusing on those with a retinopathy severity level of 47 to 53, and to consider the role of baseline characteristics and macular nonperfusion on outcomes among this particular group,” Charles Wykoff, MD, PhD, (Read more...)